In addition, a significantly higher proportion of NK (CD56+CD3−) cells from current smokers with COPD (87.5%, 75.1–96.9; p<0.005) were activated compared to healthy smokers (41.1%, 25.6–52.5) (Figure 5C). Here, NCAM1 is linked to chronic obstructive pulmonary disease.